CHMP OK Puts Merck KGaA's Cladribine Pill On EU Home Stretch After Long Trek
Merck of Germany's oral multiple sclerosis medicine cladribine looks set to finally get EU approval. But the long, slow race it has had to endure - and time lost getting there - may curb sales.